Considering that the efficacy ICIs requires CD8+ T cells infiltrations in tumor, we performed TIDE analysis based on FUSCC dataset to predict the correlation between DCLK1 expression levels and the responsiveness of ICIs in TNBC patients. The gene discussed is CD8A; the disease is neoplasm.